BLUE EARTH THERAPEUTICS LIMITEDActive
Key figures
Like most small UK companies, BLUE EARTH THERAPEUTICS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Balance sheet structure
Filed accounts2022–2025
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Cash at bank and in hand | 12,522,179 | 2,548,194 | 12,025,153 | — |
| Total assets | 13,053,818 | 3,272,834 | 15,028,959 | — |
| Total liabilities | 3,141,983 | 819,575 | 3,794,348 | — |
| Net assets / total equity | 9,911,835 | 2,453,259 | 11,234,611 | 13,486,392 |
| Average number of employees | 3 | 3 | 6 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the Company is the research and development of next-generation targeted radiotherapeutics for the treatment of cancer, with a primary focus on therapies for prostate cancer.
As described in the company's latest filed accounts.
Summary: BLUE EARTH THERAPEUTICS LIMITED
Company
BLUE EARTH THERAPEUTICS LIMITED is a private limited company registered with Companies House under company number 13229922. It was incorporated on 26 Feb 2021. Its status is active. The registered office is in Oxford (OX4). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files full accounts. Net assets were £13,486,392, up 20% on the previous year. The company had an average of 0 employees. Figures are available for 4 financial years (2022–2025).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 11 Mar 2027.